Tulisokibart (MK-7240)

tulisokibart · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tulisokibart (MK-7240), covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) [Phase 2]